Epratuzumab (LymphoCide)
Revision as of 20:37, 22 January 2018 by Warner-admin (talk | contribs) (Text replacement - "Category:Acute lymphocytic leukemia medications" to "Category:B-cell acute lymphoblastic leukemia medications")
Mechanism of action
Anti-CD22 antibody
Preliminary data
Acute lymphocytic leukemia
- Advani AS, McDonough S, Coutre S, Wood B, Radich J, Mims M, O'Donnell M, Elkins S, Becker M, Othus M, Appelbaum FR. SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia. Br J Haematol. 2014 May;165(4):504-9. Epub 2014 Mar 3. PubMed link to original article